Study Finds Brain Abnormalities in Fetuses Exposed to Zika
In a study to be presented on Jan. 27, in the oral concurrent session at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, researchers with the Baylor College of Medicine Department of Obstetrics and Gynecology, partnered with the Maternal-Fetal Unit, CEDIFETAL, Centro de Diagnostico de Ultrasonido e Imagenes, CEDIUL, Barranquilla, Columbia and the Unidad De Fertildad Y Genetica De Cartagena, Cartagena de Indias, Columbia, to create the study, "Characterization of brain malformations and volume assessment in fetuses with Zika Virus infection using MRI."
Researchers assessed fetal brain findings and volumetric composition with magnetic resonance imaging (MRI) of confirmed Zika virus infected fetuses from the recent outbreak in Barranquilla, Columbia. The fetuses were screened throughout gestation, finding brain anomalies at 29 weeks gestation.
"Up until our study, there have not been any reports focused on detailed brain imaging from the Zika outbreak in Colombia," said Magdalena Sanz-Cortes, MD, PhD, with Baylor College of Medicine's department of obstetrics and gynecology, maternal-fetal medicine specialist at Texas Children's Pavilion for Women and presenter of the study at the SMFM annual meeting. The researchers found a reduction in brain tissue and increased amount of fluid that was most pronounced in the upper brain. "Microcephaly does not happen in all Zika cases," Sanz-Cortes explained, referring to the small head size that has been characterized as a Zika symptom. The findings were similar to the findings of infected babies in Brazil.
"This research has filled a gap of knowledge for us," Sanz-Cortes continued, "these results support the recent notion that we should not rely on microcephaly to determine if a fetus or newborn has contracted the Zika Virus."
Source: Society for Maternal-Fetal Medicine
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
